During the past decade, Contact Sponsor conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Contact Sponsor" are "Coronary Artery Disease" (4 trials). Many other conditions were trialed in "Contact Sponsor" in a lesser frequency.

Most popular intervention types in "Contact Sponsor" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "drug eluting coronary stent" (2 trials), "Coronary stent" (1 trials) and "coronary stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Contact Sponsor" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Contact Sponsor". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Contact Sponsor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Contact Sponsor, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".